Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-28

Clinical Trial Update: HITT for the Identification of Mild Traumatic Brain Injury

View source ↗

Summary

A clinical trial named HITT is evaluating identification of mild traumatic brain injury; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rebiscan, Inc. | Conditions: Brain Injuries, Traumatic | Status: ACTIVE_NOT_RECRUITING